Article R1243-29 of the French Public Health Code
By way of derogation from the provisions of this section, where the tissues, their derivatives or the cells or cell therapy preparations are intended for the manufacture of a proprietary medicinal product or a medicinal product manufactured industrially or by a method involving an industrial process, the authorisation provided for in Article L. 5124-3 constitutes authorisation, for the manufacturers of pharmaceutical products mentioned in article R. 5124-2, to carry out…